Related Experiment Video
Updated: Apr 24, 2026

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
Published on: January 18, 2019
Integrin-linked kinase mediates force transduction in cardiomyocytes by modulating SERCA2a/PLN function
Alexandra Traister1, Mark Li1, Shabana Aafaqi1
1Cardiology Division, Department of Paediatrics, Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8.
Insights
Integrin-linked kinase (ILK) regulates heart muscle function by controlling calcium handling proteins. A specific ILK mutation enhances cardiac function, offering a potential therapeutic target for dilated cardiomyopathy (DCM).
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Dilated cardiomyopathy (DCM) severely impairs heart function, with no effective mechanism-based therapies available.
- The process of mechanotransduction, how mechanical forces change cardiac contractility, is poorly understood in normal and diseased hearts.
Purpose of the Study:
- To investigate the role of integrin-linked kinase (ILK) in mediating cardiomyocyte mechanotransduction in the human heart.
- To explore the potential of modulating ILK activity for treating DCM.
Main Methods:
- Investigated the interaction between ILK, sarcoplasmic/endoplasmic reticulum Ca(2+)ATPase isoform 2a (SERCA-2a), and phospholamban (PLN) in human cardiac tissue.
- Utilized a non-oncogenic ILK mutation (ILK(R211A)) to assess its impact on cardiac function.
Main Results:
- Identified ILK as a key mediator of cardiomyocyte force transduction through regulation of SERCA-2a and phospholamban (PLN) phosphorylation.
- Demonstrated that the ILK(R211A) mutation enhances global cardiac function by modulating the SERCA-2a/PLN module.
Conclusions:
- ILK links mechanical input to cardiac contractility via the SERCA-2a/PLN pathway.
- Targeting ILK and its interaction with SERCA-2a/PLN presents a novel therapeutic strategy to rescue impaired mechanotransduction in DCM.
Abstract:
Human dilated cardiomyopathy (DCM) manifests as a profound reduction in biventricular cardiac function that typically progresses to death or cardiac transplantation. There is no effective mechanism-based therapy currently available for DCM, in part because the transduction of mechanical load into dynamic changes in cardiac contractility (termed mechanotransduction) remains an incompletely understood process during both normal cardiac function and in disease states. Here we show that the mechanoreceptor protein integrin-linked kinase (ILK) mediates cardiomyocyte force transduction through regulation of the key calcium regulatory protein sarcoplasmic/endoplasmic reticulum Ca(2+)ATPase isoform 2a (SERCA-2a) and phosphorylation of phospholamban (PLN) in the human heart. A non-oncogenic ILK mutation with a synthetic point mutation in the pleckstrin homology-like domain (ILK(R211A)) is shown to enhance global cardiac function through SERCA-2a/PLN. Thus, ILK serves to link mechanoreception to the dynamic modulation of cardiac contractility through a previously undiscovered interaction with the functional SERCA-2a/PLN module that can be exploited to rescue impaired mechanotransduction in DCM.
More Related Videos
08:00Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
Published on: July 10, 2019
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Cytoskeletal Linker Proteins - Plakins
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Tension Response at Adherens Junctions
α-Catenin as a Mechanosensory Protein
The α-catenin of adherens junctions is an allosteric protein with three VH (vinculin...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
cAMP-dependent Protein Kinase Pathways